Given the increasing number of older patients with both cancer and cardiovascular disease and the potential cardiotoxic effects of many cancer therapies, creation of a new specialty called cardio-oncology or onco-cardiology has been suggested (Albini A, et al. J Natl Cancer Inst. 2010;102:14-25). New strategies for protecting against cardiotoxicity in patients treated with anthracyclines were reported at the American Heart Association Scientific Sessions 2009.
A new interventional radiology treatment that utilizes intra-arterial yttrium-90 (Y-90) microspheres may prolong the lives of many patients with hepatocellular carcinoma. New data presented at the Society of Interventional Radiology's 35th annual scientific meeting showed this approach may extend life for the more than three fourths of hepatocellular carcinoma patients who are not eligible for surgery.
Results 1 - 2 of 2